OrbiMed

Sonoran sidewinder rattlesnake
Biotech

OrbiMed’s Sidewinder slithers ahead with $137M series B for ADCs

Three years after its OrbiMed-backed series A in 2023, Sidewinder Therapeutics is adding to its nest egg courtesy of a clutch of new investors.
Darren Incorvaia Apr 8, 2026 7:00am
climbing rock climber

OrbiMed-backed Pinnacle adds $89M for oral peptides

Mar 26, 2026 10:29am
China export industry and global supply chain Cargo airplane flying over logistic containers

AirNexis swoops in with $200M series A for COPD asset

Jan 9, 2026 11:01am
purple lightning tornado

Electra shines with $183M fundraise for rare disease trial

Oct 22, 2025 8:26am
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Barinthus enters reverse merger with metabolic disease biotech

Sep 30, 2025 10:39am
Sparrow flying from a tree branch

Sparrow flits forward with $95M for midstage diabetes asset

Sep 24, 2025 11:22am